Explore the words cloud of the EBOVAC3 project. It provides you a very rough idea of what is the project "EBOVAC3" about.
The following table provides information about the project.
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
|Coordinator Country||United Kingdom [UK]|
|Total cost||29˙402˙655 €|
|EC max contribution||29˙402˙655 € (100%)|
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
|Duration (year-month-day)||from 2018-06-01 to 2023-05-31|
Take a look of project's partnership.
|1||LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER||UK (LONDON)||coordinator||11˙261˙968.00|
|2||UNIVERSITEIT ANTWERPEN||BE (ANTWERPEN)||participant||8˙541˙212.00|
|3||INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE||FR (PARIS)||participant||4˙835˙026.00|
|4||UNIVERSITY OF SIERRA LEONE||SL (FREETOWN)||participant||4˙764˙447.00|
|5||COALITION FOR EPIDEMIC PREPAREDNESS INNOVATION||NO (OSLO)||participant||0.00|
|6||JANSSEN VACCINES & PREVENTION BV||NL (LEIDEN)||participant||0.00|
The overall aim of EBOVAC3 is to support an essential part of remaining clinical and manufacturing activities required for licensure in the European Union (EU) and the United States (US) of a candidate heterologous prime-boost prophylactic vaccine regimen against Ebola virus disease that is under development at Janssen Vaccines & Prevention B.V. The intended target indication is defined as:
“A prime-boost regimen with Ad26.ZEBOV as prime vaccine and MVA-BN®-Filo as boost vaccine indicated for the prevention of Ebola virus disease (EVD) caused by EBOV of the Zaire ebolavirus species in adults and elderly (aged ≥65 years), human immunodeficiency virus (HIV)-infected adults, and children aged ≥1 year.”
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EBOVAC3" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EBOVAC3" are provided by the European Opendata Portal: CORDIS opendata.